These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 4670139)

  • 21. [Effect of nicotinate of xanthinol prolongatum on the walking distance of patients with arterial insufficiency of the lower extremities].
    Joos F; Basyn M; Rocher A
    Acta Clin Belg; 1972; 27(5):529-47. PubMed ID: 4669777
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of channeling agents on the release pattern of theophylline from kollidon SR based matrix tablets.
    Ibn Razzak MS; Khan F; Hossain M; Khan MZ; Azad MA; Reza MS
    Pak J Pharm Sci; 2009 Jul; 22(3):303-7. PubMed ID: 19553179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Theophylline molecularly imprinted polymer dissociation kinetics: a novel sustained release drug dosage mechanism.
    Norell MC; Andersson HS; Nicholls IA
    J Mol Recognit; 1998; 11(1-6):98-102. PubMed ID: 10076816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation and evaluation of a novel delayed-onset sustained-release system of propranolol hydrochloride.
    Feng XM; Ren Q; Zhang WZ; Shen HF; Rong ZX; Fang C; Chen HZ
    J Pharm Pharmacol; 2008 Jul; 60(7):817-22. PubMed ID: 18549667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blends of reverse enteric polymer with Enteric and pH-independent polymers: mechanistic investigations for tailoring drug release.
    Menjoge AR; Kulkarni MG
    Biomacromolecules; 2007 Jan; 8(1):240-51. PubMed ID: 17206813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of sustained release fast-disintegrating tablets using various polymer-coated ion-exchange resin complexes.
    Jeong SH; Park K
    Int J Pharm; 2008 Apr; 353(1-2):195-204. PubMed ID: 18164882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Absorption of theophylline from conventional and sustained-release tablets.
    Mellstrand T; Svedmyr N; Fagerström PO
    Eur J Respir Dis Suppl; 1980; 109():54-60. PubMed ID: 6934088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two galactomannans and scleroglucan as matrices for drug delivery: preparation and release studies.
    Coviello T; Alhaique F; Dorigo A; Matricardi P; Grassi M
    Eur J Pharm Biopharm; 2007 May; 66(2):200-9. PubMed ID: 17156985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hemodynamics of the isolated kidney under the effect of xanthinol nicotinate].
    Husemann B
    Arzneimittelforschung; 1970 Aug; 20(8):1069-70. PubMed ID: 5536504
    [No Abstract]   [Full Text] [Related]  

  • 30. [Comparative study on the modification of oxygen consumption of rat liver and brain homogenates by xanthinol nicotinate and nicotinic acid].
    Brenner G
    Arzneimittelforschung; 1974 Mar; 24(3):321-5. PubMed ID: 4407877
    [No Abstract]   [Full Text] [Related]  

  • 31. Absorption of alprenolol in man from tablets with different rates of release.
    Johansson R; Regårdh CG; Sjögren J
    Acta Pharm Suec; 1971 Mar; 8(1):59-70. PubMed ID: 4396952
    [No Abstract]   [Full Text] [Related]  

  • 32. Evaluation of Xantinol nicotinate (Complamina) in experimental pulmonary fibrin embolism.
    Boruah KD; Chakravarti RN; Wahi PL
    Indian J Med Res; 1974 Jun; 62(6):923-9. PubMed ID: 4435907
    [No Abstract]   [Full Text] [Related]  

  • 33. [7-(3-(METHYL-OXYETHYLAMINE)-2-OXYPROPYL)-1,3-DIMETHYL-XANTHINE NICOTINATE IN ADVANCED VASCULAR DISEASES].
    FEUNEDECOLOMBI G; SCIARROTTA NO; DUSSAUT A
    Sem Med; 1963 Jul; 123():17-22. PubMed ID: 14084888
    [No Abstract]   [Full Text] [Related]  

  • 34. [Research on the capillaroscopic picture in subjects with arterial diseases with obliterating course. 2. Action of theophylline, theophylline nicotinate, and 3-pyridinemethanol].
    MAZZONE O; BLASI A
    Riforma Med; 1962 Sep; 76():1073-6. PubMed ID: 13934264
    [No Abstract]   [Full Text] [Related]  

  • 35. DETERMINATION OF IN VIVO AND IN VITRO RELEASE OF THEOPHYLLINE AMINOISOBUTANOL IN A PROLONGED-ACTION SYSTEM.
    KAPLAN LL
    J Pharm Sci; 1965 Mar; 54():457-8. PubMed ID: 14301582
    [No Abstract]   [Full Text] [Related]  

  • 36. Proceedings: Mode of action of xanthinol-nicotinate on the human ERG.
    Hellner KA; Bohnhoff HJ
    Exp Eye Res; 1973 Nov; 17(4):391. PubMed ID: 4765271
    [No Abstract]   [Full Text] [Related]  

  • 37. A comparative study of the absorption of xanthinol nicotinate from slow-release and plain tablets in man.
    Sharma PL; Garg SK; Sikka SC
    Int J Clin Pharmacol; 1973 Jul; 7(4):299-302. PubMed ID: 4146912
    [No Abstract]   [Full Text] [Related]  

  • 38. Kinetics of liquid capillary penetration into inert polymer matrices.
    Carli F; Simioni L
    Pharm Acta Helv; 1978; 53(11):320-6. PubMed ID: 746041
    [No Abstract]   [Full Text] [Related]  

  • 39. A new application of lipid nanoemulsions as coating agent, providing zero-order hydrophilic drug release from tablets.
    Anton N; de Crevoisier A; Schmitt S; Vandamme T
    J Drug Deliv; 2012; 2012():271319. PubMed ID: 22272376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cellulose acetate phthalate coating of tablets disintegrating at a predetermined intestinal position].
    Dragsted L; Boesen E; Wielandt TO; Krag E
    Ugeskr Laeger; 1979 May; 141(20):1328-30. PubMed ID: 452142
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.